Article
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
Blood cells, molecules & diseases - 1 Nov 2016
Friedrisch João Ricardo, Sheehan Vivien, Flanagan Jonathan M, Baldan Alessandro, Summarell Carly C Ginter, Bittar Christina Matzembacher, Friedrisch Bruno Kras, Wilke Ianaê Indiara, Ribeiro Camila Blos, Daudt Liane Esteves, da Rocha Silla Lucia Mariano
Abstract excerpt
High levels of fetal hemoglobin (HbF) reduce sickle cell anemia (SCA) morbidity and mortality. HbF levels vary considerably and there is a strong genetic component that influences HbF production. Genetic polymorphisms at three quantitative trait loci (QTL): Xmn1-HBG2, HMIP-2 and BCL11A, have been shown to influence HbF levels and disease severity in SCA. Hydroxyurea (HU) is a drug that increases HbF. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.